ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "108: FSHD Radio Hot off the Press: Mel Hayes of Fulcrum with a REACH Trial Update"
Episode Synopsis
Earlier this month, Fulcrum Therapeutics confirmed the completion of patient enrollment in the Phase 3 REACH clinical trial for losmapimod, a potential groundbreaking therapy for FSHD. Mel Hayes, Chief Operating Officer of Fulcrum sat down with Tim to discuss what this exciting milestone means and fill us in on the latest from Project Mercury.
Catch a new Hot off the Press episode on the 4th Thursday of every month. Listen on your favorite podcast app or watch on YouTube or Facebook. Subscribe to make sure you never miss an episode!
Catch a new Hot off the Press episode on the 4th Thursday of every month. Listen on your favorite podcast app or watch on YouTube or Facebook. Subscribe to make sure you never miss an episode!
More episodes of the podcast FSHD Straight Talk with Tim Hollenback
158: Always a Work in Progress: Growth through Movement, Connection, and Adapation with Elissa
28/10/2025
155: 2025 Walk & Roll Special
20/09/2025
153: More Laughter, More Love: Reflections on an Inter-Abled Relationship with Leah & Joe Lee
12/08/2025
In God we trust